Latest filing published 28 Jan 2026 for MAAT PHARMA, €155k. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Seventure Partners Societe Anonyme A Directoire is a declared insider of Maat Pharma, with filings sourced from AMF. In total, 38 filings cover trades dated from 3 December 2021 to 27 January 2026.
On the open market, the record shows 1 purchase worth €1.3M and 37 sales worth €2.7M. Sales outweigh purchases by €1.4M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2026: no purchases and 6 sales on the market.
The record was last updated on 28 January 2026 with an open-market sale (€155k) in Maat Pharma. The clock since the last published purchase (17 May 2024) now reads 883 days. Filings reach the AMF feed a median of 2 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from AMF. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 38 declarations